No Data
Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates
There's No Escaping Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Muted Revenues Despite A 41% Share Price Rise
Evercore Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $30
Express News | Kiniksa Pharmaceuticals Ltd. : Wells Fargo Raises Target Price to $35 From $34
Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $35
Earnings Call Summary | Kiniksa Pharmaceuticals International(KNSA.US) Q2 2024 Earnings Conference